These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12357032

  • 21. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis.
    Huang C, Ma WY, Li J, Hecht SS, Dong Z.
    Cancer Res; 1998 Sep 15; 58(18):4102-6. PubMed ID: 9751619
    [Abstract] [Full Text] [Related]

  • 22. Base excision DNA repair defect in Gadd45a-deficient cells.
    Jung HJ, Kim EH, Mun JY, Park S, Smith ML, Han SS, Seo YR.
    Oncogene; 2007 Nov 29; 26(54):7517-25. PubMed ID: 17599061
    [Abstract] [Full Text] [Related]

  • 23. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism.
    Hainaut P, Rolley N, Davies M, Milner J.
    Oncogene; 1995 Jan 05; 10(1):27-32. PubMed ID: 7824276
    [Abstract] [Full Text] [Related]

  • 24. Selenomethionine or methylseleninic acid inhibits mutagenesis of a reporter gene in mouse bone marrow.
    Kumar MS, Pollok KE, Smith ML.
    Anticancer Res; 2010 Feb 05; 30(2):291-3. PubMed ID: 20332431
    [Abstract] [Full Text] [Related]

  • 25. The organic selenium compound selenomethionine modulates bleomycin-induced DNA damage and repair in human leukocytes.
    Laffon B, Valdiglesias V, Pásaro E, Méndez J.
    Biol Trace Elem Res; 2010 Jan 05; 133(1):12-9. PubMed ID: 19468696
    [Abstract] [Full Text] [Related]

  • 26. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells.
    Chen D, Yu Z, Zhu Z, Lopez CD.
    Cancer Res; 2006 Apr 01; 66(7):3485-94. PubMed ID: 16585172
    [Abstract] [Full Text] [Related]

  • 27. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury.
    Lewén A, Sugawara T, Gasche Y, Fujimura M, Chan PH.
    Neurobiol Dis; 2001 Jun 01; 8(3):380-90. PubMed ID: 11447995
    [Abstract] [Full Text] [Related]

  • 28. Dynamics and diversions in base excision DNA repair of oxidized abasic lesions.
    Demple B, DeMott MS.
    Oncogene; 2002 Dec 16; 21(58):8926-34. PubMed ID: 12483509
    [No Abstract] [Full Text] [Related]

  • 29. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
    Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, Gius D.
    Cancer Res; 2000 Dec 01; 60(23):6688-95. PubMed ID: 11118054
    [Abstract] [Full Text] [Related]

  • 30. Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides.
    Schwartz TR, Kmiec EB.
    BMC Mol Biol; 2007 Jan 26; 8():7. PubMed ID: 17257432
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors.
    Cheo DL, Meira LB, Burns DK, Reis AM, Issac T, Friedberg EC.
    Cancer Res; 2000 Mar 15; 60(6):1580-4. PubMed ID: 10749126
    [Abstract] [Full Text] [Related]

  • 33. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P, Milner J.
    Cancer Res; 1993 Oct 01; 53(19):4469-73. PubMed ID: 8402615
    [Abstract] [Full Text] [Related]

  • 34. Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair.
    Fischer JL, Mihelc EM, Pollok KE, Smith ML.
    Mol Cancer Ther; 2007 Jan 01; 6(1):355-61. PubMed ID: 17237294
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
    Bissonnette N, Wasylyk B, Hunting DJ.
    Biochem Cell Biol; 1997 Jan 01; 75(4):351-8. PubMed ID: 9493957
    [Abstract] [Full Text] [Related]

  • 37. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
    Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB, Wynshaw-Boris A.
    Hum Mol Genet; 2005 Jun 15; 14(12):1699-708. PubMed ID: 15888486
    [Abstract] [Full Text] [Related]

  • 38. Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence.
    Hafsi H, Hainaut P.
    Antioxid Redox Signal; 2011 Sep 15; 15(6):1655-67. PubMed ID: 21194382
    [Abstract] [Full Text] [Related]

  • 39. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R, El-Deiry WS.
    Oncogene; 2000 Mar 30; 19(14):1735-43. PubMed ID: 10777207
    [Abstract] [Full Text] [Related]

  • 40. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
    Seemann S, Hainaut P.
    Oncogene; 2005 Jun 02; 24(24):3853-63. PubMed ID: 15824742
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.